Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women

Archives of Gynecology and Obstetrics

Volumn 289, Issue 6, 2014, Pages 1281-1286

  Hillemanns, Peter ^a   Jentschke, Matthias ^a   Evans, Thomas G ^b   Soergel, Philipp ^a   Hass, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cervical cancer; CIN; E6 AP; HPV

Indexed keywords

E6 ASSOCIATED PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN P16; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; DISEASE ASSOCIATION; E6 ASSOCIATED PROTEIN GENE; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; WART VIRUS;

ADULT; BIOPSY, NEEDLE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84905088454     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3120-5     Document Type: Article

References (20)

1. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P et al (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ(Clinical research ed) 337:a1284
2. Brun JL, Dalstein V, Leveque J, Mathevet P, Raulic P, Baldauf JJ et al (2011) Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy. Am J Obstet Gynecol 204(2):169e1-169e8
3. Einstein MH, Kadish AS, Burk RD, Kim MY, Wadler S, Streicher H et al (2007) Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol Oncol 106(3):453-460 (Pubitemid 47302460)
4. Young JL, Jazaeri AA, Darus CJ, Modesitt SC (2008) Cyclooxygenase-2 in cervical neoplasia: a review. Gynecol Oncol 109(1):140-145
5. Hillemanns P, Wang X, Hertel H, Andikyan V, Hillemanns M, Stepp H et al (2008) Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia. Am J Obstet Gynecol 198(3):300e1-300e7
6. Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2(5):342-350
7. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103(5):368-383
8. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8:3905-3910 (Pubitemid 20016074)
9. Munger K, Phelps WC, Bubb V, Howley PH, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417-4421 (Pubitemid 19229441)
10. Peralta-Zaragoza O, Bermudez-Morales VH, Madrid-Marina V (2010) RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer. Rev Invest Clin 62(1):63-80
11. Chen XZ, Zhu KJ, Xu Y, Tang XY, Cai XZ, Zhang X et al (2010) RNA interference silences the human papillomavirus 6b/11 early gene E7 in vitro and in vivo. Clin Exp Dermatol 35(5):509-515
12. Hengstermann A, D'Silva MA, Kuballa P, Butz K, Hoppe-Seyler F, Scheffner M (2005) Growth suppression induced by down-regulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J Virol 79(14):9296-9300 (Pubitemid 40934840)
13. Tomaic V, Pim D, Banks L (2009) The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 393(1):7-10
14. Shai A, Pitot HC, Lambert PF (2010) E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res 70(12):5064-5073
15. Opalinska JB, Gewirtz AM (2002) Nucleic-acid therapeutics: basic principles and recent applications. Nat Rev Drug Discov 1(7):503-514 (Pubitemid 37361504)
16. Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY et al (2004) Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 165(6):2177-2185 (Pubitemid 39578394)
17. Mizui T, Yamashina S, Tanida I, Takei Y, Ueno T, Sakamoto N et al (2010) Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. J Gastroenterol 45(2):195-203
18. Jonson AL, Rogers LM, Ramakrishnan S, Downs LS Jr (2008) Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Gynecol Oncol 111(2):356-364
19. Jung HS, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK et al (2011) The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo. Int J Cancer 130(8):1925-1936
20. Yamato K, Egawa N, Endo S, Ui-Tei K, Yamada T, Saigo K et al (2011) Enhanced specificity of HPV16 E6E7 siRNA by RNA-DNA chimera modification. Cancer Gene Ther 18(8):587-597